Targeting EYA2 tyrosine phosphatase activity in glioblastoma stem cells induces mitotic catastrophe

2021 ◽  
Vol 218 (11) ◽  
Author(s):  
Guoxin Zhang ◽  
Zhen Dong ◽  
Ryan C. Gimple ◽  
Arthur Wolin ◽  
Qiulian Wu ◽  
...  

Glioblastoma ranks among the most lethal of primary brain malignancies, with glioblastoma stem cells (GSCs) at the apex of tumor cellular hierarchies. Here, to discover novel therapeutic GSC targets, we interrogated gene expression profiles from GSCs, differentiated glioblastoma cells (DGCs), and neural stem cells (NSCs), revealing EYA2 as preferentially expressed by GSCs. Targeting EYA2 impaired GSC maintenance and induced cell cycle arrest, apoptosis, and loss of self-renewal. EYA2 displayed novel localization to centrosomes in GSCs, and EYA2 tyrosine (Tyr) phosphatase activity was essential for proper mitotic spindle assembly and survival of GSCs. Inhibition of the EYA2 Tyr phosphatase activity, via genetic or pharmacological means, mimicked EYA2 loss in GSCs in vitro and extended the survival of tumor-bearing mice. Supporting the clinical relevance of these findings, EYA2 portends poor patient prognosis in glioblastoma. Collectively, our data indicate that EYA2 phosphatase function plays selective critical roles in the growth and survival of GSCs, potentially offering a high therapeutic index for EYA2 inhibitors.

2012 ◽  
Vol 302 (1) ◽  
pp. G10-G20 ◽  
Author(s):  
S. Ramalingam ◽  
G. W. Daughtridge ◽  
M. J. Johnston ◽  
A. D. Gracz ◽  
S. T. Magness

Sox9 is an high-mobility group box transcription factor that is expressed in the stem cell zone of the small intestine and colon. We have previously used a Sox9EGFP mouse model to demonstrate that discrete levels of Sox9 expression mark small intestine epithelial stem cells that form crypt/villus-like structures in a three-dimensional culture system (Formeister EJ, Sionas AL, Lorance DK, Barkley CL, Lee GH, Magness ST. Am J Physiol Gastrointest Liver Physiol 296: G1108–G1118, 2009; Gracz AD, Ramalingam S, Magness ST. Am J Physiol Gastrointest Liver Physiol 298: G590–G600, 2010). In the present study, we hypothesized that discrete levels of Sox9 expression would also mark colonic epithelial stem cells (CESCs). Using the Sox9EGFP mouse model, we show that lower levels of Sox9 mark cells in the transit-amplifying progenitor cell zone, while higher levels of Sox9 mark cells in the colonic crypt base. Furthermore, we demonstrate that variable SOX9 levels persist in cells of colonic adenomas from mice and humans. Cells expressing lower Sox9 levels demonstrate gene expression profiles consistent with more differentiated populations, and cells expressing higher Sox9 levels are consistent with less differentiated populations. When placed in culture, cells expressing the highest levels of Sox9 formed “colonoids,” which are defined as bodies of cultured colonic epithelial cells that possess multiple cryptlike structures and a pseudolumen. Cells expressing the highest levels of Sox9 also demonstrate multipotency and self-renewal in vitro, indicating functional stemness. These data suggest a dose-dependent role for Sox9 in normal CESCs and cells comprising colon tumors. Furthermore, distinct Sox9 levels represent a new biomarker to study CESC and progenitor biology in physiological and disease states.


2016 ◽  
Vol 2016 ◽  
pp. 1-11
Author(s):  
Yi Wang ◽  
Youguo Ying ◽  
Xiaoyan Cui

Mesenchymal stem cells (MSCs) are multipotential cells with capability to form coloniesin vitroand differentiate into distinctive end-stage cell types. Although MSCs secrete many cytokines, the efficacy can be improved through combination with neurotrophic factors (NTFs). Moreover, MSCs are excellent opportunities for local delivery of NTFs into injured tissues. The aim of this present study is to evaluate the effects of overexpressing NTFs on proliferation and differentiation of human umbilical cord-derived mesenchymal stem cells (HUMSCs). Overexpressing NTFs had no effect on cell proliferation. Overexpressing NT-3, BDNF, and NGF also had no significant effect on the differentiation of HUMSCs. Overexpressing NTFs all promoted the neurite outgrowth of embryonic chick E9 dorsal root ganglion (DRG). The gene expression profiles of the control and NT-3- and BDNF-modified HUMSCs were compared using RNA sequencing and biological processes and activities were revealed. This study provides novel information about the effects of overexpressing NTFs on HUMSCs and insight into the choice of optimal NTFs for combined cell and gene therapy.


Blood ◽  
2019 ◽  
Vol 134 (Supplement_1) ◽  
pp. 2474-2474
Author(s):  
Valgardur Sigurdsson ◽  
Shuhei Koide ◽  
Visnja Radulovic ◽  
Els Mansell ◽  
Mark Van Der Garde ◽  
...  

Hematopoietic stem cells (HSCs) are capable of replenishing the entire blood system when needed and transplantation of HSCs remains as one of the most effective, curative treatments for patients with genetic diseases and hematopoietic malignancies. In vitro culture is an essential process for ex vivo expansion and modification of HSCs, however engraftment levels of cultured HSCs cannot be accurately estimated. This is mainly due to lack of reliable cell surface markers representing functionality of HSCs after culture, which also limits the resolution of molecular analyses. We have previously shown that HSCs are vulnerable to endoplasmic reticulum (ER) stress responses fueled by accumulation of unfolded / misfolded proteins (Miharada et al., Cell Rep. 2014). Importance of ER stress suppression is also evident in vivo, as proliferative FL-HSCs fail to expand upon ER stress induction when natural molecular chaperone, bile acid, is reduced (Sigurdsson et al., Cell Stem Cell. 2016). Thus, ER stress elevation severely impairs the potential of HSCs, however usual marker profile is no longer representative of their functionality. In this study we aimed to discover the key signature and novel markers that represent functional retardation of HSC under activation and stress induction. Initially we compared gene expression profiles of fresh and 14-days cultured Lineage-Sca-1+c-kit+(LSK) CD48- (CD48-LSK) cells from mouse bone marrow using microarray analysis, since CD48 has been reported to enrich functional HSCs after in vitro culture (Noda et al., Stem Cells, 2008). We discovered abnormal up-regulations of genes frequently associated with mast cells (MC) in cultured CD48-LSK cells, and identified Cd244 as one of the top upregulated genes. CD244 is a member of the slam family of genes but is considered to be redundant with other slam markers in isolating HSCs from untreated mice. Indeed, freshly isolated CD150+CD48-LSK cells are negative for CD244. However, after 14-days in vitro culture with stem cell factor (SCF) and thrombopoietin (TPO), majority of CD150+CD48-LSK cells were positive for CD244. After shorter (7-days) culture, we found that CD48-LSK cells could be subdivided to CD244+ and CD244- populations (CD244-HSC and CD244+HSC). CD244-HSCs expressed high levels of HSC-related genes such as Fgd5, Hlf, Fhl1 and thrombopoietin receptor Mpl, In contrast, CD244+HSCs expressed MC-related genes, e.g. Cpa3, Gzmb and Mcpt8. In transplantation settings, CD244+HSCs showed no engraftment while CD244-HSCs showed long-term engraftment revealing them as functional stem cells. Since our and other groups have demonstrated that induction of ER stress impairs potential of mouse and human HSCs, we asked if ER stress induction would lead to the elevation of MC signature. Using an ER stress inducing chemical, thapsigargin, we could see increased ratio of CD244+HSCs within CD48-LSK cells. Conversely, the addition of TUDCA, a bile acid known to suppress ER stress, resulted in decreased frequency of CD244+HSCs. These findings strongly indicate that ER stress could be influencing the number of non-functional HSCs. To further substantiate the connection to ER stress and MC signature we analyzed a knock out mouse model of the ER stress modulator Trib3 (Trib3-/-) that is known to show an abnormal differentiation towards mast cells. Trib3-/- HSCs expressed MC genes including Cpa3 already at the steady-state condition. The number of CD244-HSCs after 7-days culture was significantly lower than control mice, and showed poor long-term engraftment potential in transplantation settings. To further elucidate the key molecular changes that impair HSCs, we compared gene expression profiles between fresh HSCs and CD244+/CD244-HSCs after 7-days culture. Gene expression comparison between CD244+ and CD244-HSCs independently confirmed the enrichment of MC cell related genes including Granzyme B (Gzmb), known to have negative impact on HSC potential (Carnevali et al., J Exp Med. 2014). Moreover, the Rel-A pathway was significantly lower in CD244-HSCs compared to fresh HSCs, suggesting a potential implication of NF-kB signal in the first alterations in HSCs during in vitro culture. We conclude that the induction of a MC cell signature fueled by ER stress is critical for normal HSC potential, and CD244 is a novel marker predicting the functionality of activated HSCs and allowing more detailed molecular analysis of activated HSCs. Disclosures No relevant conflicts of interest to declare.


2010 ◽  
Vol 38 (4) ◽  
pp. 1037-1045 ◽  
Author(s):  
Emily Dick ◽  
Divya Rajamohan ◽  
Jonathon Ronksley ◽  
Chris Denning

Functional cardiomyocytes can now be derived routinely from hPSCs (human pluripotent stem cells), which collectively include embryonic and induced pluripotent stem cells. This technology presents new opportunities to develop pharmacologically relevant in vitro screens to detect cardiotoxicity, with a view to improving patient safety while reducing the economic burden to industry arising from high drug attrition rates. In the present article, we consider the need for human cardiomyocytes in drug-screening campaigns and review the strategies used to differentiate hPSCs towards the cardiac lineage. During early stages of differentiation, hPSC-cardiomyocytes display gene expression profiles, ultra-structures, ion channel functionality and pharmacological responses reminiscent of an embryonic phenotype, but maturation during extended time in culture has been demonstrated convincingly. Notably, hPSC-cardiomyocytes have been shown to respond in a highly predictable manner to over 40 compounds that have a known pharmacological effect on the human heart. This suggests that further development and validation of the hPSC-cardiomyocyte model as a tool for assessing cardiotoxicity is warranted.


Blood ◽  
1997 ◽  
Vol 90 (4) ◽  
pp. 1435-1447 ◽  
Author(s):  
Andrew G. Elefanty ◽  
Lorraine Robb ◽  
Raquella Birner ◽  
C. Glenn Begley

Abstract The helix-loop-helix transcription factor, scl, plays an essential role in hematopoietic development. Embryos in which the gene has been disrupted fail to develop yolk sac erythropoiesis, and scl-null embryonic stem cells do not contribute to hematopoiesis in chimeric mice. To analyze the molecular consequences of scl deficiency, we compared the gene expression profiles of control (wild-type and scl-heterozygous) and scl-null embryonic stem cells differentiated in vitro for up to 12 days. In control and scl-null embryoid bodies the temporal expression pattern of genes associated with the formation of ventral mesoderm, such as Brachyury, bone morphogenetic protein-4, and flk-1, was identical. Similarly, GATA-2, CD34, and c-kit, which are coexpressed in endothelial and hematopoietic lineages, were expressed normally in scl-null embryonic stem cell lines. However, hematopoietic-restricted genes, including the transcription factors GATA-1, EKLF, and PU.1 as well as globin genes and myeloperoxidase, were only expressed in wild-type and scl-heterozygous embryonic stem cells. Indirect immunofluorescence was used to confirm the observations that GATA-1 and globins were only present in control embryoid bodies but that CD34 was found on both control and scl-null embryoid bodies. These data extend the previous gene ablation studies and support a model whereby scl is absolutely required for commitment of a putative hemangioblast to the hematopoietic lineage but that it is dispensable for endothelial differentiation.


Blood ◽  
2012 ◽  
Vol 119 (11) ◽  
pp. 2510-2522 ◽  
Author(s):  
Stephen B. Ting ◽  
Eric Deneault ◽  
Kristin Hope ◽  
Sonia Cellot ◽  
Jalila Chagraoui ◽  
...  

Abstract The stem cell–intrinsic model of self-renewal via asymmetric cell division (ACD) posits that fate determinants be partitioned unequally between daughter cells to either activate or suppress the stemness state. ACD is a purported mechanism by which hematopoietic stem cells (HSCs) self-renew, but definitive evidence for this cellular process remains open to conjecture. To address this issue, we chose 73 candidate genes that function within the cell polarity network to identify potential determinants that may concomitantly alter HSC fate while also exhibiting asymmetric segregation at cell division. Initial gene-expression profiles of polarity candidates showed high and differential expression in both HSCs and leukemia stem cells. Altered HSC fate was assessed by our established in vitro to in vivo screen on a subcohort of candidate polarity genes, which revealed 6 novel positive regulators of HSC function: Ap2a2, Gpsm2, Tmod1, Kif3a, Racgap1, and Ccnb1. Interestingly, live-cell videomicroscopy of the endocytic protein AP2A2 shows instances of asymmetric segregation during HSC/progenitor cell cytokinesis. These results contribute further evidence that ACD is functional in HSC self-renewal, suggest a role for Ap2a2 in HSC activity, and provide a unique opportunity to prospectively analyze progeny from HSC asymmetric divisions.


Blood ◽  
1997 ◽  
Vol 90 (4) ◽  
pp. 1435-1447 ◽  
Author(s):  
Andrew G. Elefanty ◽  
Lorraine Robb ◽  
Raquella Birner ◽  
C. Glenn Begley

The helix-loop-helix transcription factor, scl, plays an essential role in hematopoietic development. Embryos in which the gene has been disrupted fail to develop yolk sac erythropoiesis, and scl-null embryonic stem cells do not contribute to hematopoiesis in chimeric mice. To analyze the molecular consequences of scl deficiency, we compared the gene expression profiles of control (wild-type and scl-heterozygous) and scl-null embryonic stem cells differentiated in vitro for up to 12 days. In control and scl-null embryoid bodies the temporal expression pattern of genes associated with the formation of ventral mesoderm, such as Brachyury, bone morphogenetic protein-4, and flk-1, was identical. Similarly, GATA-2, CD34, and c-kit, which are coexpressed in endothelial and hematopoietic lineages, were expressed normally in scl-null embryonic stem cell lines. However, hematopoietic-restricted genes, including the transcription factors GATA-1, EKLF, and PU.1 as well as globin genes and myeloperoxidase, were only expressed in wild-type and scl-heterozygous embryonic stem cells. Indirect immunofluorescence was used to confirm the observations that GATA-1 and globins were only present in control embryoid bodies but that CD34 was found on both control and scl-null embryoid bodies. These data extend the previous gene ablation studies and support a model whereby scl is absolutely required for commitment of a putative hemangioblast to the hematopoietic lineage but that it is dispensable for endothelial differentiation.


2020 ◽  
Author(s):  
Wenyong Fei ◽  
Mingsheng Liu ◽  
Yao Zhang ◽  
Shichao Cao ◽  
Xuanqi Wang ◽  
...  

Abstract Purpose: The study aims to determine the process of myoginc differentiation in human pluripotent stem cells and to figure out that the key pathways and hub genes in the process, which do helpful for the further research of muscular regeneration.Method: Three gene expression profiles, GSE131125, GSE148994, GSE149055, about the comparisons of pluripotent stem cells and myogenic stem cells from the Gene Expression Omnibus (GEO) data base. Common differentially expressed genes (DEGs) were obtained and for the further analysis as Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and GSEA analysis and protein‑protein interaction (PPI) network. In vitro cell research to verify the hub genes and key pathways.Result:824 DEGs were co-expressed in the three GSEs. 19 hub genes were identified from the PPI network. The GO and KEGG pathway analysis were performed to determine the functions of DEGs. GSEA analysis indicated the differentiated cells were enriched in muscle cell development and myogenesis.Conclusion: Our research revealed the main hub genes and modules in the myogeinc process of stem cells which contribute to further study about the molecular mechanism of myogenesis regeneration. Paving a way for more accurate treatment for muscle dysfunction.


2019 ◽  
Author(s):  
Andrea Bisso ◽  
Marco Filipuzzi ◽  
Gianni Paolo Gamarra Figueroa ◽  
Giulia Brumana ◽  
Francesca Biagioni ◽  
...  

AbstractBackground & AimsActivation of MYC and CTNNB1 (encoding β-catenin) can co-occur in liver cancer, but how these oncogenes cooperate in tumorigenesis remains unclear.Approach & ResultsWe generated a mouse model allowing conditional activation of MYC and WNT/β-catenin signaling (through either β-catenin activation or Apc loss) upon expression of CRE recombinase in the liver, and monitored their effects on hepatocyte proliferation, apoptosis, gene expression profiles and tumorigenesis. Conditional activation of WNT/β-catenin signaling strongly accelerated MYC-driven carcinogenesis in the mouse liver. Both pathways also cooperated in promoting cellular transformation in vitro, demonstrating their cell-autonomous action. Short-term induction of MYC and β-catenin in hepatocytes followed by RNA-seq profiling allowed the identification of a “Myc/β-catenin signature”, composed of a discrete set of Myc-activated genes whose expression increased in presence of active β-catenin. Notably this signature enriched for targets of Yap and Taz, two transcriptional co-activators known to be activated by WNT/β-catenin signaling, and to cooperate with MYC in mitogenic activation and liver transformation. Consistent with these regulatory connections, Yap/Taz accumulated upon Myc/β-catenin activation and were required not only for the ensuing proliferative response, but also for tumor cell growth and survival. Finally, the Myc/β-catenin signature was enriched in a subset of human hepatocellular carcinomas characterized by comparatively poor prognosis.ConclusionsYap and Taz mediate the cooperative action of Myc and β-catenin in liver tumorigenesis. This warrants efforts toward therapeutic targeting of Yap/Taz in aggressive liver tumors marked by elevated Myc/β-catenin activity.


Sign in / Sign up

Export Citation Format

Share Document